The Raf kinase inhibitors Dabrafenib and Regorafenib impair Zika virus replication via distinct mechanisms. Wilken L, Rimmelzwaan GF, Elbahesh H. J Virol 2024 Jul 18:e0061824. doi: 10.1128/jvi.00618.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wilken L, Rimmelzwaan GF, Elbahesh H. The Raf kinase inhibitors Dabrafenib and Regorafenib impair Zika virus replication via distinct mechanisms. J Virol 2024 Jul 18:e0061824. doi: 10.1128/jvi.00618.
PMID: 39023323